Publicaciones en colaboración con investigadores/as de VU University Medical Center (4)

2018

  1. A genetic polymorphism in ctla-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma

    Clinical Cancer Research, Vol. 24, Núm. 10, pp. 2350-2356

2017

  1. Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma

    Pharmacogenetics and Genomics, Vol. 27, Núm. 6, pp. 227-231

  2. Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients

    Oncotarget, Vol. 8, Núm. 1, pp. 1204-1212

2015

  1. Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

    European Journal of Clinical Pharmacology, Vol. 71, Núm. 12, pp. 1477-1484